Assessment of Estrogen Receptor Expression in Epithelial Ovarian Cancer Patients Using 16α-<sup>18</sup>F-Fluoro-17β-Estradiol PET/CT - Concepedia

Concepedia

Publication | Open Access

Assessment of Estrogen Receptor Expression in Epithelial Ovarian Cancer Patients Using 16α-<sup>18</sup>F-Fluoro-17β-Estradiol PET/CT

DOI Full Paper Access

55

Citations

30

References

2014

Year

Michel van Kruchten, Erik F. J. de Vries, Henriëtte J.G. Arts, Neeltina M. Jager, Alphons H.H. Bongaerts, Andor W.J.M. Glaudemans, Harry Hollema, Elisabeth G.E. de Vries, Geke A.P. Hospers, Anna K.L. Reyners

Journal of Nuclear Medicine

Abstract

(18)F-FES PET/CT can reliably assess ERα status in epithelial ovarian cancer tumors and metastases noninvasively. Evaluation of the predictive value of (18)F-FES PET/CT for endocrine therapy in epithelial ovarian cancer patients is warranted.

References

	Year	Citations

Page 1